No Data
No Data
Hong Kong stocks fluctuate | CRO concept stocks collectively decline, the industry still faces short-term pressure, and industry clearance is expected to improve the market share of leading companies.
CRO concept stocks collectively fell. As of the time of publication, Pharmaron (03759) fell 3.22%, reporting 8.73 Hong Kong dollars; Wuxi Apptec (02359) fell 3.04%, reporting 30.25 Hong Kong dollars; Tigermed (03347) fell 2.84%, reporting 29.05 Hong Kong dollars.
Wuxi AppTec (02359.HK): 218,700 shares of bonus shares have been awarded to 24 selected participants.
As of the announcement date, 218,651 reward shares have been granted to 24 selected participants, accounting for approximately 0.0565% of the total number of H shares issued by the company as of the announcement date and approximately 0.0075% of the total issued share capital. The aforementioned reward shares are existing shares that are purchased by the trustee through on-market trades at prevailing market prices in accordance with the company's instructions. As the company will not grant additional new shares, such further grants will not have any dilutive effect on the equity interests of existing shareholders.
Japan Contract Development Manufacturing Organization Market Report 2024-2030, Featuring Lonza, Recipharm, LabCorp, Catalent, WuXi AppTec, CordenPharma, Cambrex, Bushu Pharmaceuticals and Nipro
Wuxi AppTec (603259.SH) 2023 equity distribution: each share is distributed 0.98974 yuan.
Wuxi Apptec (603259.SH) released an announcement on the implementation of annual equity distribution in 2023: The current A shares will have a dividend of...
WuXi AppTec Goes Ex Dividend Tomorrow
Trending Industry Today: TIGERMED Leads Losses In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
June 14th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(LIST1261.HK)$ is trending lower today with 9 constituents down and TIGERMED leading Losses.$TIGERMED
No Data